Longer-term Tolerability and Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Autism Spectrum Disorder: An Open-label Phase 2 Study (BRIGHT [ZYN2-CL-030])

Category Primary study
JournalPediatrics
Year 2022
This article has no abstract
Epistemonikos ID: a626f2ccb39858270594a0e387e09b33ce0d3b89
First added on: Feb 14, 2025